MINI FUTURE LONG - SMITH & NEPHEW | Market Closed - Börse Stuttgart 10:36:58 2024-07-12 am EDT | ||
| 2.88 EUR | +6.27% |
|
| Current month | +79.47% | ||
| 1 month | +31.55% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
SMITH & NEPHEW PLC
Latest news about SMITH & NEPHEW PLC
More news
| Date | Price | Change |
|---|---|---|
| 24-07-12 | 2.88 | +6.27% |
| 24-07-11 | 2.71 | -2.17% |
| 24-07-10 | 2.77 | +6.54% |
| 24-07-09 | 2.6 | +4.42% |
| 24-07-08 | 2.49 | -1.97% |
Delayed Quote Börse Stuttgart
Last update July 12, 2024 at 10:36 am EDT
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | SMITH & NEPHEW PLC |
| Issuer | Morgan Stanley |
| WKN | MG1DZG |
| ISIN | DE000MG1DZG3 |
| Date issued | 2024-04-03 |
| Strike | 857.3 p |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 1.81 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.88 € |
|---|---|
| Lowest since issue | 1.3 € |
Company Profile
Smith & Nephew Plc specializes in designing, manufacturing and marketing medical products and equipment. Net sales break down by activity sector as follows:
- orthopedic surgery (39.9%): primarily orthopedic implants (hips, knees and shoulders);
- sports medicine, arthroscopy and cervicofacial surgery (31.2%): surgery and damaged tissue repair products and instruments, visualization products, etc.;
- wound care (28.9%): skin grafts for major burns victims, treatments for leg ulcers, etc.
The United States accounts for 53.7% of net sales.
Sector
-
Consensus: Smith & Nephew Plc
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
14.29
USD
Average target price
16.41
USD
Spread / Average Target
+14.82%
- Stock Market
- Certificates
- Certificat
